Oral Vancomycin and Abdominal Distention
Oral vancomycin is not typically associated with abdominal distention as a direct adverse effect, but it may indirectly contribute to abdominal distention in patients with severe Clostridioides difficile infection (CDI), particularly those with ileus or megacolon.
Mechanism and Pharmacokinetics
- Oral vancomycin is poorly absorbed from the gastrointestinal tract in most patients with normal intestinal mucosa, which is why it's effective for treating CDI while minimizing systemic effects 1
- In patients with severe colitis or disrupted intestinal epithelial integrity, absorption may increase, potentially leading to detectable serum concentrations 1, 2
- High doses of vancomycin (500 mg four times daily), prolonged exposure, and renal failure can increase the risk of systemic absorption 1
Clinical Considerations
Relationship to Abdominal Distention
- Abdominal distention is not listed as a direct adverse effect of oral vancomycin in clinical practice guidelines 1
- However, in patients with severe or fulminant CDI, abdominal distention may occur as part of the disease process, manifesting as:
Management Considerations for Patients with Abdominal Distention
If abdominal distention is present due to ileus in a patient requiring vancomycin:
- Vancomycin can be administered rectally as a retention enema (500 mg in approximately 100 mL normal saline every 6 hours) 1
- Intravenous metronidazole (500 mg every 8 hours) should be administered together with oral or rectal vancomycin 1
- Higher doses of oral vancomycin (up to 500 mg four times daily) may be considered in fulminant CDI 1
For patients with severe abdominal distention suggesting megacolon or perforation:
Rare Adverse Effects of Oral Vancomycin
While abdominal distention is not a commonly reported adverse effect, other rare adverse reactions to oral vancomycin have been documented:
- Rash in patients with acute kidney injury (due to increased systemic absorption) 3
- Elevation of liver enzyme levels (ALT to 371 U/L and AST to 203 U/L) 4
- In one study of patients with chronic idiopathic constipation, oral vancomycin actually improved stool frequency, consistency, and ease of defecation rather than causing distention 5
Clinical Pearls
- Monitor for signs of systemic absorption of oral vancomycin in patients with:
- If abdominal distention develops or worsens during oral vancomycin therapy, evaluate for:
In summary, while oral vancomycin itself is not a direct cause of abdominal distention, clinicians should be vigilant about monitoring for abdominal distention as a sign of worsening CDI or development of complications that may require modification of the treatment approach.